COVID-19 Testing: More details
COVID-19 Resources: More details
TORONTO--(BUSINESS WIRE)--SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE: SOL) (OTCPK: SOLCF) (Frankfurt: 9SB) is pleased to announce that it has completed an investment in Common C Holdings LP (“Common C Holdings”), a Michigan-base
SASKATOON, Saskatchewan--(BUSINESS WIRE)--Nutrien Ltd (TSX and NYSE: NTR) announced today that Mr. Mark Thompson, Nutrien’s Executive Vice President, Chief Strategy and Sustainability Officer, will be speaking at the Raymond James 2021 Diversified Indus
TORONTO--(BUSINESS WIRE)--NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment announced today a Memorandum of Understanding (“MoU”) with T
Deal marks second agreement with Takeda this year for access to Genevant’s LNP technology Genevant eligible for up to $303 million in upfront and potential milestone payments, plus royalties on product sales VANCOUVER, British Columbia & BASEL, Switze
LAVAL, Quebec--(BUSINESS WIRE)--BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic cough (“RCC”) and oth
– KVD824 Clinical Trial Regulatory Approvals in Canada, Australia, and the UK – – Response Submitted to FDA on IND Requests for KVD824 Phase 2 – CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--$KALV--KalVista Pharmaceuticals, Inc. (NASDA
VANCOUVER, British Columbia--(BUSINESS WIRE)--$ACOG--Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition,” or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the l
TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its unique hydrogen sulfide platform to develop safer medicines for pain and inflammation, is pleased to announce the results of its annual me
Sales of $3.2M in July 2021 set a new monthly record, exceeding the previous monthly record of $2.1M in May, 2021 Headset, Inc. data published in June 2021 shows Heritage achieved one of the top growth rates for extract sales in the first half of ca
Further strengthens competitively advantaged Plant-Based Foods and Beverages business growth Adds capacity to enable doubling of the business in 5 years Financing expected to come from lease and term loan facilities, and be operational in late 2022 MIN
Sustainable Protein Food Systems: Meeting Future Needs
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.